Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways

Abstract

Defects in p53 and nuclear factor-kappa B (NF-κB) signaling pathways are frequently observed in the initiation and development of various human malignancies, including prostate cancer. Clinical studies demonstrate higher expression of NF-κB/p65/RelA, NF-κB/p50/RelB, and cRel as well as downregulation of the p53 network in primary prostate cancer specimens and in metastatic tumors. Betulinic acid (BA), is a triterpenoid that has been reported to be an effective inducer of apoptosis through modification of several signaling pathways. Our objective was to investigate the pathways involved in BA-induced apoptosis in human prostate cancer cells. We employed the androgen-responsive LNCaP cells harboring wild-type p53, and androgen-refractory DU145 cells possessing mutated p53 with high constitutive NF-κB activity. Inhibition of cell survival by BA at 10 and 20 μM concentrations occurred as a result of alteration in Bax/Bcl-2 ratio in both cell lines that led to an increased cytochrome C release, caspase activation and poly(ADP)ribose polymerase (PARP) cleavage, leading to apoptosis. BA treatment resulted in stabilization of p53 through increase in phosphorylation at Ser15 in LNCaP cells, but not in DU145 cells, and induction of cyclin kinase inhibitor p21/Waf1 in both cell types. Furthermore, treatment of both prostate cancer cells with BA decreased the phosphorylation of IκB kinase (IKK)α and I-kappa-B-alpha (IκBα) inhibiting the nuclear location of NF-κB/p65 causing cytosolic accumulation and resulting in its decreased nuclear binding. We demonstrate that BA may induce apoptosis by stabilizing p53 and downregulating NF-κB pathway in human prostate cancer cells, irrespective of the androgen association, and therefore can potentially be developed as a molecule of interest in cancer chemoprevention.

A Novel Near-infrared Fluorescent Protein, iRFP720, Facilitates Transcriptional Profiling of Prostate Cancer Bone Metastasis in Mice

“…Furthermore, iRFP720 excitation at >700 nm and emission from 810-875 nm enables it to be detected with high specificity, with associated technical complexity and costs that are much less than those of luciferin-based bioluminescence imaging, which is also highly specific. Both p53 and mammalian target of rapamycin (mTOR) pathways are important for prostate cancer progression (7)(8)(9). Our pathway analysis results are consistent with such evidence.…”

Effects and mechanisms of betulinic acid on improving EGFR TKI‐resistance of lung cancer cells

“…BetA also induced cytotoxicity and apoptosis in human breast cancer cells (MCF‐7 and T47D) . BetA, via stabilizing p53 and regulation of the NF‐κB pathway, increases the Bax/Bcl‐2 ratio that leads to an increased cytochrome C release, caspase activation, and apoptosis in human prostate cancer cells (LNCaP and DU145) . BetA inhibits growth and induces proteasome regulation of specificity proteins transcription factors in colon cancer cells (RKO and SW480), and BetA decreases specificity protein 1 level to inhibit cell growth in lung cancer cells (A549 and H1299) .…”

MiR‐1207‐5p/CX3CR1 axis regulates the progression of osteoarthritis via the modulation of the activity of NF‐κB pathway

“…46 Through phosphorylating IκBα, the NF-κB pathway was activated and further induced apoptosis. 47 F I G U R E 5 Micro RNA (miR)-1207-5p blocked the lipopolysaccharide (LPS)induced activation of nuclear factor (NF)-κB signaling pathway via suppressing the expression of C-X3-C motif chemokine receptor 1 (CX3CR1). A, Western blot experiment was implemented to examine the protein expression levels of IκBα, p-IκBα, P65 and p-P65.…”